Targeting HSP70‐E7 Interaction With SHetA2: A Novel Therapeutic Strategy for Cervical CancerJustin Garland(University of Oklahoma Health Sciences Center), Doris M. Benbrook(Oklahoma State University Oklahoma City)Journal of Medical VirologyNovember 1, 202410.1002/jmv.70088Cited by 5SaveCiteExport RISWatch citationsRelated PapersComplementary Targeting of Rb Phosphorylation and Growth in Cervical Cancer Cell Cultures and a Xenograft Mouse Model by SHetA2 and Palbociclib|Cancers|2020|14Manipulation of metabolic responses enhances SHetA2 efficacy without toxicity in cervical cancer cell lines and xenografts|Gynecologic Oncology|2023|4